Clinical Trial Update: An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice [Phase 4]

View source ↗

Summary

Phase 4 open-label trial evaluating the real-world efficacy, tolerability, and safety of Lantus (insulin glargine) in patients with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED